Vol.

No.

June 21, 2019Jun 21, 2019

DOWNLOAD THE PDF

How a Flatiron hackathon team linked Medicaid expansion with reduction in racial disparities in time to cancer treatment

Cover Story

Free

How a Flatiron hackathon team linked Medicaid expansion with reduction in racial disparities in time to cancer treatment

By Matthew Bin Han Ong

Last December, Flatiron Health convened a “hackathon,” an event where programmers, developers, and scientists pitch novel ideas and aggressively crunch data in a competitive sprint.

Conversation with The Cancer Letter

Flatiron's Adamson: Medicaid disparities study shows real world data is valuable for assessing policy

By Matthew Bin Han Ong

House bill gives NIH a $2B increase, but battle over budget caps looms

By Paul Goldberg

Film & TV Free

Chernobyl, the HBO miniseries: Fact and fiction (Part IV)

By Robert Peter Gale

NCI advisors approve 23 concepts at joint NCAB/BSA meeting

By Claire Dietz

Clinical Trials & Tribulations

Lessons from the front lines of value-based care:
The OCM's impact on community oncology

By Charles Saunders

In Brief

Cathy Eng named co-leader of GI cancer program at Vanderbilt

Mark Bonnen named chair of radiation oncology at UT Health San Antonio

Steven Shak to receive Leadership in Personalized Medicine Award

Upal Basu Roy named vice president of research at LUNGevity

Thomas J. Smith awarded ASCO/Walther Cancer Foundation palliative and supportive care award

ASCO announces Health Policy Leadership Development Program fellows

Stephanie Dutton receives Susan G. Komen Greater Pennsylvania award

Northwell opens Pancreatic Cancer Center

Clinical Roundup

Study finds one in six cancer survivors reported pain restricting daily functioning

Radiation + chemo doesn't improve endometrial cancer recurrence-free survival

Mount Sinai researchers show first link between exposure to dust from 9/11 attack and prostate cancer

Drugs & Targets

FDA approves pembrolizumab for metastatic SCLC

FDA approves Amgen and Allergan's Kanjinti, Herceptin biosimilar

Lynparza approved in EU for ovarian cancer

Lynparza approved in Japan for ovarian cancer

Myriad receives second insurance reimbursement decision for its BRACAnalysis in Japan

Gilead, Nurix form collaboration to develop cancer therapies

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 06 - February 14, 2025